Eagle Asset Management Inc Emergent Bio Solutions Inc. Transaction History

Eagle Asset Management Inc

$16.7 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$11.0 - $21.45 $45,991 - $89,682	-4,181 Reduced 2.61%	155,972 $1.84 Million
Q3 2022 Nov 07, 2022	BUY	$20.09 - $35.8 $1.23 Million - $2.2 Million	61,422 Added 62.21%	160,153 $3.36 Million
Q2 2022 Aug 10, 2022	SELL	$27.42 - $43.63 $2.43 Million - $3.87 Million	-88,635 Reduced 47.31%	98,731 $3.06 Million
Q1 2022 May 12, 2022	SELL	$36.48 - $52.22 $287,498 - $411,545	-7,881 Reduced 4.04%	187,366 $7.69 Million
Q4 2021 Feb 11, 2022	BUY	$33.11 - $55.01 $1.46 Million - $2.42 Million	44,032 Added 29.12%	195,247 $8.81 Million
Q3 2021 Nov 10, 2021	SELL	$50.07 - $66.05 $300,570 - $396,498	-6,003 Reduced 3.82%	151,215 $7.57 Million
Q2 2021 Aug 11, 2021	SELL	$56.61 - $80.46 $20.4 Million - $29 Million	-360,820 Reduced 69.65%	157,218 $9.9 Million
Q1 2021 May 14, 2021	SELL	$86.23 - $125.19 $4.31 Million - $6.25 Million	-49,946 Reduced 8.79%	518,038 $41.7 Million
Q4 2020 Feb 12, 2021	BUY	$79.17 - $111.47 $99,437 - $140,006	1,256 Added 0.22%	567,984 $50.9 Million
Q3 2020 Nov 12, 2020	BUY	$81.91 - $134.94 $2.07 Million - $3.42 Million	25,323 Added 4.68%	566,728 $59.1 Million
Q2 2020 Aug 12, 2020	BUY	$54.33 - $89.52 $16.7 Million - $27.6 Million	308,241 Added 132.2%	541,405 $40.8 Million
Q1 2020 May 11, 2020	SELL	$49.34 - $68.76 $2.45 Million - $3.42 Million	-49,694 Reduced 17.57%	233,164 $13.5 Million
Q4 2019 Feb 07, 2020	SELL	$51.21 - $59.06 $1.5 Million - $1.73 Million	-29,366 Reduced 9.41%	282,858 $15.3 Million
Q3 2019 Nov 04, 2019	BUY	$40.6 - $57.2 $227,035 - $319,862	5,592 Added 1.82%	312,224 $16.3 Million
Q2 2019 Aug 05, 2019	BUY	$39.92 - $53.86 $3.89 Million - $5.24 Million	97,374 Added 46.53%	306,632 $14.8 Million
Q1 2019 May 01, 2019	BUY	$48.23 - $66.16 $1.37 Million - $1.88 Million	28,473 Added 15.75%	209,258 $10.6 Million
Q4 2018 Feb 11, 2019	BUY	$55.63 - $73.24 $1.92 Million - $2.52 Million	34,425 Added 23.52%	180,785 $10.7 Million
Q3 2018 Nov 08, 2018	SELL	$52.05 - $66.51 $97,958 - $125,171	-1,882 Reduced 1.27%	146,360 $9.63 Million
Q2 2018 Aug 07, 2018	SELL	$48.33 - $55.64 $540,957 - $622,778	-11,193 Reduced 7.02%	148,242 $7.48 Million
Q1 2018 May 09, 2018	BUY	$44.44 - $54.39 $703,618 - $861,156	15,833 Added 11.03%	159,435 $8.39 Million
Q4 2017 Feb 09, 2018	SELL	$37.77 - $47.75 $4.15 Million - $5.24 Million	-109,771 Reduced 43.32%	143,602 $6.67 Million
Q3 2017 Nov 09, 2017	BUY	$34.14 - $40.45 $8.65 Million - $10.2 Million	253,373	253,373 $10.5 Million

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$32.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$28.6 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$21 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$18.7 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$16.1 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Account